GKGabriela Kania

Gabriela Kania

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriela Kania has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alan Valaperti

    From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...

    1 shared publication
  • Christian M. Matter

    From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...

    1 shared publication
  • Davide Germano

    From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...

    1 shared publication
  • Lukas Hunziker

    Department of Cardiology, Inselpital, Bern University Hospital, Freiburgstrasse 10 , 3010 Bern

    1 shared publication
  • Przemyslaw Blyszczuk

    Department of Clinical Immunology, Faculty of Medicine (M. Stefanska, P.B.), Jagiellonian University Medical College, Cracow, Poland

    1 shared publication
  • Sokrates Stein

    Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland

    1 shared publication

Latest Publications

  • Heart-Infiltrating Prominin-1 + /CD133 + Progenitor Cells Represent the Cellular Source of Transforming Growth Factor β–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis

    by Gabriela Kania, Przemyslaw Blyszczuk, Sokrates Stein, Alan Valaperti, Davide Germano, Stephan Dirnhofer, Lukas Hunziker, Christian M. Matter, Urs Eriksson

    Rationale : Myocardial fibrosis is a hallmark of inflammation-triggered end-stage heart disease, a common cause of heart failure in young patients. Objective : We used CD4 + T-cell–mediated experimental autoimmune myocarditis model to determine the parameters regulating cardiac fibrosis in inflammatory heart disease. Methods and Results : α-Myosin heavy chain peptide/complete Freund’s adjuvant immunization was used to induce experimental autoimmune myocarditis in BALB/c mice. Chimeric mice, reconstituted with enhanced green fluorescence protein (EGFP) + bone marrow, were used to track the fate of inflammatory cells. Prominin-1 + cells were isolated from the inflamed hearts, cultured in vitro and injected intracardially at different stages of experimental autoimmune myocarditis. Transforming growth factor (TGF)-β–mediated fibrosis was addressed using anti–TGF-β antibody treatment. Myocarditis peaked 21 days after immunization and numbers of cardiac fibroblasts progressively increased on follow-up. In chimeric mice, >60% of cardiac fibroblasts were EGFP + 46 days after immunization. At day 21, cardiac infiltrates contained ≈30% of prominin-1 + progenitors. In vitro and in vivo experiments confirmed that prominin-1 + but not prominin-1 − cells isolated from acutely inflamed hearts represented the cellular source of cardiac fibroblasts at late stages of disease, characterized by increased TGF-β levels within the myocardium. Mechanistically, the in vitro differentiation of heart-infiltrating prominin-1 + cells into fibroblasts depended on TGF-β–mediated phosphorylation of Smad proteins. Accordingly, anti–TGF-β antibody treatment prevented myocardial fibrosis in immunized mice. Conclusions : Taken together, heart-infiltrating prominin-1 + progenitors are the major source of subsequent TGF-β–triggered cardiac fibrosis in experimental autoimmune myocarditis. Recognizing the critical, cytokine-dependent role of bone marrow–derived progenitors in cardiac remodeling might result in novel treatment concepts against inflammatory heart failure.